The universal wireless power and data platform combines innovative technology, validated engineering tools, and rapid integration services to help implantable device companies reduce development risk and accelerate commercialization.
BURLINGTON, Vt., Sept. 29, 2026 /PRNewswire-PRWeb/ -- Resonant Link Medical, an innovative medical technology company redefining wireless power and data transfer for implantable devices, today announced the launch of Vivigo™ 2.0, its next-generation wireless power platform for implantable medical devices. Built on Resonant Link Medical's proven Aurion WPT™ technology, Vivigo™ gives device developers a ready-to-integrate platform for wireless power that reduces risk, accelerates development, and helps bring life-changing technologies to market faster. The platform delivers ultra-fast wireless energy transfer over an extended range, enabling a new generation of implantable technologies that are smaller, smarter, and longer lasting. It supports both rechargeable implants, with charging in as little as 20 minutes, and battery-free devices requiring uninterrupted wireless power.
For decades, most implantable medical devices were intentionally designed around the limitations of non-rechargeable batteries because developing safe, reliable, and patient-friendly wireless power systems was too complex, too risky, and too difficult to integrate. Today, implantable devices are evolving beyond simple therapy delivery to incorporate continuous sensing, high-speed data transfer, artificial intelligence, and closed-loop algorithms. Together, these capabilities require substantially more power than previous generations of implantable devices, making advanced wireless power an essential enabling technology. Vivigo™ changes the equation by providing a wireless power platform that reduces development risk and gives innovators the confidence to build the next generation of smaller, smarter, longer-lasting implantable medical devices.
"Implantable devices are becoming dramatically more intelligent, but they can't become more intelligent without fundamentally rethinking how they're powered," said Omari Bouknight, CEO of Resonant Link Medical. "Vivigo™ gives innovators an advanced wireless power platform that enables smaller, smarter implantable devices designed for MRI compatibility while reducing development risk and accelerating the path to commercialization. Medical device companies shouldn't have to become wireless power experts to bring breakthrough therapies to patients. With Vivigo™, they can build on our platform and focus their time, energy, and innovation where it matters most: creating the next generation of intelligent implantable medicine."
Media Contact
Rachel Allard, Resonant Link Medical, 1 802-448-8220, [email protected], https://rlmedical.com/
SOURCE Resonant Link Medical
Share this article